{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:41:33Z","timestamp":1773290493276,"version":"3.50.1"},"reference-count":16,"publisher":"National Center for Global Health and Medicine (JST)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["GHM"],"published-print":{"date-parts":[[2021,4,30]]},"DOI":"10.35772\/ghm.2020.01106","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T22:07:23Z","timestamp":1612994843000},"page":"62-66","source":"Crossref","is-referenced-by-count":8,"title":["Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan"],"prefix":"10.35772","volume":"3","author":[{"given":"Sho","family":"Saito","sequence":"first","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Mikami","sequence":"additional","affiliation":[{"name":"Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinyu","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Funazaki","sequence":"additional","affiliation":[{"name":"Clinical Trial Management Section, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Ashida","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhito","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Kokudo","sequence":"additional","affiliation":[{"name":"National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21485","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Arshad Ali S, Baloch M, Ahmed N, Arshad Ali A, Iqbal A. The outbreak of Coronavirus Disease 2019 (COVID-19)An emerging global health threat. J Infect Public Health. 2020; 13:644-646.","DOI":"10.1016\/j.jiph.2020.02.033"},{"key":"2","unstructured":"2. Ministry of Health, Labor and Welfare. The first confirmed case of COVID-19 in Japan. January 16, 2020. <i>https:\/\/www.mhlw.go.jp\/stf\/newpage_08906.html<\/i> (accessed June 2, 2020) (in Japanese)."},{"key":"3","unstructured":"3. Ministry of Health, Labor and Welfare. Situation report, Fig. No. of positive cases. <i>https:\/\/www.mhlw.go.jp\/stf\/covid-19\/kokunainohasseijoukyou_00006.html#1-1 <\/i>(accessed October 15, 2020)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sheahan TP, Sims AC, Graham RL, <i>et al<\/i>. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017; 9:eaal3653.","DOI":"10.1126\/scitranslmed.aal3653"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Grein J, Ohmagari N, Shin D, <i>et al<\/i>. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020; 382:2327-2336.","DOI":"10.1056\/NEJMc2015312"},{"key":"6","unstructured":"6. National Center for Global Health and Medicine. Feel the NCGM, Special Edition. Sep 2020. <i>https:\/\/www.ncgm.go.jp\/covid19\/PDF\/Feel_the_NCGM_SP.pdf <\/i>(accessed October 15, 2020) (in Japanese)."},{"key":"7","unstructured":"7. Beigel JH, Tomashek KM, Dodd LE, <i>et al<\/i>. Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. 2020 May 22. <i>https:\/\/escholarship.umassmed.edu\/covid19\/40\/<\/i> (accessed October 15, 2020)"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Beigel JH, Tomashek KM, Dodd LE, <i>et al<\/i>. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020; 383:1813-1826.","DOI":"10.1056\/NEJMc2022236"},{"key":"9","unstructured":"9. U.S. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment. May 1, 2020. <i>https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment<\/i> (accessed January 5, 2021)."},{"key":"10","unstructured":"10. Ministry of Health, Labor and Welfare. Special Approval for Emergency on Remdesivir for COVID-19. May 8, 2020.<i> https:\/\/www.pmda.go.jp\/english\/int-activities\/0004.pdf<\/i> (accessed January 5, 2021)."},{"key":"11","unstructured":"11. Ministry of Health, Labor and Welfare. Special Approval for Emergency on Remdesivir for COVID-19 in accordance to Pharmaceutical and Medical Device Act. Press Release. May 7 2020. <i>https:\/\/www.mhlw.go.jp\/content\/000628076.pdf<\/i> (accessed January 5, 2021) (in Japanese)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. U.S. Food and Drug Administration. FDA Approves First Treatment for COVID-19. October 22, 2020. <i>https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-covid-19<\/i> (accessed January 5, 2021).","DOI":"10.1002\/cpu.30542"},{"key":"13","unstructured":"13. U.S. Food and Drug Administration. Frequently Asked Questions for Veklury (remdesivir). Updated December 8, 2020. <i>https:\/\/www.fda.gov\/media\/137574\/download<\/i> (accessed January 5, 2021)."},{"key":"14","unstructured":"14. Handling of Notification of Clinical Trial Plans for Novel Coronavirus Infections. Ministry of Health, Labor and Welfare, ed. March 19 2020. <i>https:\/\/www.mhlw.go.jp\/hourei\/doc\/tsuchi\/T200323I0040.pdf<\/i> (accessed June 2, 2020) (in Japanese)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020; 382:1564-1567.","DOI":"10.1056\/NEJMc2004973"},{"key":"16","unstructured":"16. Handling of the retention of consent documents in clinical trials. Ministry of Health, Labor and Welfare, ed. April 7, 2020. <i>https:\/\/www.mhlw.go.jp\/hourei\/doc\/tsuchi\/T200408I0010.pdf<\/i> (accessed June 2, 2020) (in Japanese)."}],"container-title":["Global Health &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghm\/3\/2\/3_2020.01106\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T05:04:59Z","timestamp":1620450299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghm\/3\/2\/3_2020.01106\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.35772\/ghm.2020.01106","relation":{},"ISSN":["2434-9186","2434-9194"],"issn-type":[{"value":"2434-9186","type":"print"},{"value":"2434-9194","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]}}}